Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What is the Expected Growth Rate of the Migraine Drugs Market from 2024 to 2033?
The migraine drugs market has grown strongly in recent years, expected to rise from $5 billion in 2023 to $5.38 billion in 2024, with a CAGR of 7.5%. The growth is driven by advancements in drug formulations, increased awareness and diagnoses, stress and lifestyle factors, expansion of generic drugs, and the emergence of CGRP inhibitors.
The migraine drugs market will grow to $6.84 billion by 2028, with a CAGR of 6.2%. This growth is attributed to personalized medicine, telemedicine, healthcare policies, rising global migraine prevalence, and combination therapies. Trends include targeted therapies, digital therapeutics, and biosimilars in migraine treatment.
Claim Your Free Sample of the Global Migraine Drugs Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=13484&type=smp
What Key Factors Are Fueling the Growth of the Migraine Drugs Market?
The growing female population is expected to drive the growth of the migraine drugs market. The prevalence of migraines is notably higher in females, influenced by genetic, hormonal, and environmental factors. According to the United Nations’ World Population Prospects 2022, the global female population is estimated at 4.00 billion, making up 49.75% of the world’s population. Projections suggest that females will outnumber males by 2049. This growing female population is a key factor in the expansion of the migraine drugs market.
What Are the Major Segments of the Migraine Drugs Market?
1) By Drug Class: Triptans, Betablockers, Angiotensin Blockers, Tricyclics, Anticonvulsants
2) By Route of Administration: Oral, Injectable, Other Routes
3) By End-User: Hospitals And Clinics, Retail Pharmacy, Online Pharmacy, Other End Users
What New Trends Are Transforming the Migraine Drugs Market?
Companies in the migraine drugs market are focusing on innovative treatments like Zavzpret to better serve patients and gain a competitive edge. Zavzpret is a nasal spray medication developed for the acute treatment of migraines. In March 2023, Pfizer received approval from the U.S. Food and Drug Administration (FDA) for Zavzpret, the first approved zavegepant nasal spray for migraine treatment. It targets the calcitonin gene-related peptide (CGRP) and is especially beneficial for patients with migraines who experience nausea or cardiovascular risks that prevent the use of triptans.
Order Now for Fast Delivery of Your Migraine Drugs Market Report!
https://www.thebusinessresearchcompany.com/report/migraine-drugs-global-market-report
Which Regions Are Driving Growth in the Migraine Drugs Market?
North America was the largest region in the migraine market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the migraine drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The Migraine Drugs Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the migraine drugs market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Migraine Drugs Market Include
1. Migraine Drugs Market Executive Summary
2. Migraine Drugs Market Segments
3. Migraine Drugs Market Size And Template Market Growth Rate
4. Key Migraine Drugs Market Trends
5. Major Migraine Drugs Market Drivers
……
25. Key Mergers And Acquisitions In The Migraine Drugs Market
26. Top Migraine Drugs Companies
27. Migraine Drugs Market Opportunities And Strategies
28. Migraine Drugs Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Preeclampsia Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/preeclampsia-drugs-global-market-report
Myelodysplastic Syndrome (MDS) Drugs Global Market Report 2024
Complicated Skin And Skin Structure Infections Drugs Global Market Report 2024
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
